Targeting Staphylococcus aureus biofilm-related infections on implanted material with a novel dual-action thermosensitive hydrogel containing vancomycin and a tri-enzymatic cocktail: in vitro and in vivo studies

被引:0
作者
Mbuku, Randy Buzisa [1 ,2 ,3 ]
Poilvache, Herve [2 ]
Maigret, Loic [3 ]
Vanbever, Rita [4 ]
Van Bambeke, Francoise [2 ]
Cornu, Olivier [1 ,3 ]
机构
[1] Catholic Univ Louvain, Inst Rech Expt & Clin, Neuromusculoskeletal Lab, Brussels, Belgium
[2] Catholic Univ Louvain, Louvain Drug Res Inst, Pharmacol cellulaire & Mol, Brussels, Belgium
[3] Clin Univ St Luc, Orthopaed & trauma Surg Dept, Brussels, Belgium
[4] Catholic Univ Louvain, Louvain Drug Res Inst, Adv Drug Delivery & Biomat, Brussels, Belgium
关键词
Biofilm; Vancomycin; Enzymatic cocktail; Poloxamer P407 hydrogel; Implant infection; Tissue cage model; CONTROLLED-RELEASE; MOXIFLOXACIN; ANTIBIOTICS; CIPROFLOXACIN; ARTHROPLASTY; PENETRATION; DETACHMENT; EFFICACY; AGENTS;
D O I
10.1016/j.bioflm.2025.100288
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Implant-associated infections remain a critical challenge due to the presence of biofilm-forming bacteria, which enhance tolerance to conventional treatments. This study investigates the efficacy of a tri-enzymatic cocktail (TEC; DNA/RNA endonuclease, endo-14-beta-D-glucanase, beta-N-acetylhexosaminidase) targeting biofilm matrix components combined with supratherapeutic doses of antibiotics encapsulated in a thermosensitive hydrogel (poloxamer P407) for local administration. In vitro, the hydrogel formulation enabled controlled release of active agents over 12 h. Vancomycin and TEC co-formulated in hydrogel achieved up to 3.8 Log10 CFU count reduction and 80 % biofilm biomass reduction on MRSA biofilms grown on titanium coupons, demonstrating enhanced efficacy as compared to individual active agents, with 1.3-3.2 log10 additional killing. Fluoroquinolone efficacy remained unchanged by enzyme addition. In vivo, in a model of tissue cages containing titanium beads implanted in the back of guinea pigs, hydrogel-delivered vancomycin maintained therapeutic levels for seven days. Coupled with an intraperitoneal administration of vancomycin for 4 days, a single local administration of hydrogel containing both vancomycin and TEC was more effective than hydrogels containing either vancomycin or TEC, achieving an additional 2.1 Log10 CFU reduction compared to local vancomycin, 2.3 Log10 compared to local TEC, and 4.3 Log10 compared to systemic vancomycin treatment alone. However, partial regrowth occurred at later stages, indicating room for further optimization. Nevertheless, these findings already underscore the potential of combining a high dose of antibiotic with an enzymatic cocktail in a sustained-release hydrogel delivery system as a promising strategy for improving the management of biofilm-associated implant infections.
引用
收藏
页数:16
相关论文
共 70 条
[61]   Biofilms as Promoters of Bacterial Antibiotic Resistance and Tolerance [J].
Uruen, Cristina ;
Chopo-Escuin, Gema ;
Tommassen, Jan ;
Mainar-Jaime, Raul C. ;
Arenas, Jesus .
ANTIBIOTICS-BASEL, 2021, 10 (01) :1-36
[62]   Controlled release of vancomycin from Poloxamer 407 gels [J].
Veyries, ML ;
Couarraze, G ;
Geiger, S ;
Agnely, F ;
Massias, L ;
Kunzli, B ;
Faurisson, F ;
Rouveix, B .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 192 (02) :183-193
[63]   Original Article Repurposing DNase I and alginate lyase to degrade the biofilm matrix of dual-species biofilms of Staphylococcus aureus and Pseudomonas aeruginosa grown in artificial sputum medium: In-vitro assessment of their activity in combination with broad-spectrum antibiotics [J].
Wang, Zhifen ;
Vanbever, Rita ;
Lorent, Joseph H. ;
Solis, Jessica ;
Knoop, Christiane ;
Van Bambeke, Francoise .
JOURNAL OF CYSTIC FIBROSIS, 2024, 23 (06) :1146-1152
[64]   CORRELATION BETWEEN INVIVO AND INVITRO EFFICACY OF ANTIMICROBIAL AGENTS AGAINST FOREIGN-BODY INFECTIONS [J].
WIDMER, AF ;
FREI, R ;
RAJACIC, Z ;
ZIMMERLI, W .
JOURNAL OF INFECTIOUS DISEASES, 1990, 162 (01) :96-102
[65]   Mortality, patient-reported outcome measures, and the health economic burden of prosthetic joint infection [J].
Xu, Yangqi ;
Huang, Tony B. ;
Schuetz, Michael A. ;
Choong, Peter F. M. .
EFORT OPEN REVIEWS, 2023, 8 (09) :690-697
[66]   Surviving as a Community: Antibiotic Tolerance and Persistence in Bacterial Biofilms [J].
Yan, Jing ;
Bassler, Bonnie L. .
CELL HOST & MICROBE, 2019, 26 (01) :15-21
[67]   Ciprofloxacin population pharmacokinetics during long-term treatment of osteoarticular infections [J].
Zahr, Noel ;
Urien, Saik ;
Aubry, Alexandra ;
Chauvin, Charlotte ;
Comets, Emmanuelle ;
Llopis, Benoit ;
Tissot, Nadine ;
Noe, Gaelle ;
Fourniols, Eric ;
Jaureguiberry, Stephane ;
Bleibtreu, Alexandre ;
Funck-Brentano, Christian .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2021, 76 (11) :2906-2913
[68]   PATHOGENESIS OF FOREIGN-BODY INFECTION - DESCRIPTION AND CHARACTERISTICS OF AN ANIMAL-MODEL [J].
ZIMMERLI, W ;
WALDVOGEL, FA ;
VAUDAUX, P ;
NYDEGGER, UE .
JOURNAL OF INFECTIOUS DISEASES, 1982, 146 (04) :487-497
[69]   Production of cellulose and curli fimbriae by members of the family Enterobacteriaceae isolated from the human gastrointestinal tract [J].
Zogaj, X ;
Bokranz, W ;
Nimtz, M ;
Römling, U .
INFECTION AND IMMUNITY, 2003, 71 (07) :4151-4158
[70]   Synovial vancomycin and meropenem concentrations in periprosthetic joint infection treated by single-stage revision combined with intra-articular infusion [J].
Zou, C. ;
Guo, W. ;
Mu, W. ;
Wahafu, T. ;
Li, Y. ;
Hua, L. ;
Xu, B. ;
Cao, L. .
BONE & JOINT RESEARCH, 2024, 13 (10) :535-545